LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 213 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $358,621 | +348.3% | 5,985 | +563.5% | 0.00% | 0.0% |
| Q2 2022 | $80,000 | -20.0% | 902 | +1.1% | 0.00% | 0.0% |
| Q1 2022 | $100,000 | -51.7% | 892 | -33.3% | 0.00% | 0.0% |
| Q4 2021 | $207,000 | -1.4% | 1,337 | -11.4% | 0.00% | -50.0% |
| Q3 2021 | $210,000 | +8.8% | 1,509 | +2.4% | 0.00% | 0.0% |
| Q2 2021 | $193,000 | -14.2% | 1,474 | -0.1% | 0.00% | 0.0% |
| Q1 2021 | $225,000 | +1775.0% | 1,475 | +1150.0% | 0.00% | – |
| Q4 2020 | $12,000 | +9.1% | 118 | +4.4% | 0.00% | – |
| Q3 2020 | $11,000 | -83.1% | 113 | -80.6% | 0.00% | -100.0% |
| Q2 2020 | $65,000 | -41.4% | 583 | -64.3% | 0.00% | -50.0% |
| Q1 2020 | $111,000 | +200.0% | 1,632 | +338.7% | 0.00% | +100.0% |
| Q3 2019 | $37,000 | -11.9% | 372 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $42,000 | 0.0% | 372 | +12.0% | 0.00% | 0.0% |
| Q1 2019 | $42,000 | +281.8% | 332 | +300.0% | 0.00% | +100.0% |
| Q4 2018 | $11,000 | -52.2% | 83 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $23,000 | +2200.0% | 83 | +2666.7% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 3 | -66.7% | 0.00% | – |
| Q1 2018 | $1,000 | – | 9 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |